Hot Topics in NASH: Current Controversies and New Developments in Fatty Liver Disease

What should our patients with NAFLD eat? Expert faculty explore the evidence behind different diets in NAFLD/NASH.

Rotonya Carr, MD Raymond E. Soccio, MD, PhD Released: November 7, 2019

Listen as expert hepatologist faculty explore the evidence behind different diets in NAFLD/NASH.

Rotonya Carr, MD Released: November 25, 2019

Listen as expert endocrinologist faculty explore the evidence behind different diets in NAFLD/NASH.

Raymond E. Soccio, MD, PhD Released: November 25, 2019

Explore the latest on NASH screening and the interplay between NAFLD, metabolic syndrome, CV risk, and diabetes risk.

Kenneth Cusi, MD, FACP, FACE Brent A. Neuschwander-Tetri, MD Released: November 22, 2019

Listen as expert hepatologist faculty explore NASH screening and interplay between NAFLD, metabolic syndrome, CV risk, diabetes risk.

Brent A. Neuschwander-Tetri, MD Released: December 3, 2019

Listen as expert endocrinologist faculty explore NASH screening and interplay among NAFLD, metabolic syndrome, CV risk, diabetes risk.

Kenneth Cusi, MD, FACP, FACE Released: December 5, 2019

Weigh the latest perspectives on wet biomarkers, imaging, and combination tests.

Rita Basu, MD Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: December 6, 2019

Listen as expert hepatologist faculty weigh the latest perspectives on wet biomarkers, imaging, and combination tests.

Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: December 16, 2019

Listen as expert endocrinologist faculty weigh the latest perspectives on wet biomarkers, imaging, and combination tests.

Rita Basu, MD Released: January 23, 2020

Learn the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.

Juan Pablo Frias, MD, FACE Philip N. Newsome, PhD, FRCPE Released: December 13, 2019

Listen as expert hepatologist faculty discuss the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.

Philip N. Newsome, PhD, FRCPE Released: January 3, 2020

Listen as expert endocrinologist faculty discuss the place of available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance.

Juan Pablo Frias, MD, FACE Released: December 18, 2019

Listen as expert endocrinologist faculty discuss agents in late-phase clinical trials and their potential use in treatment.

Juan Pablo Frias, MD, FACE Released: February 5, 2020

Listen as expert hepatologist faculty agents in late-phase clinical trials and their potential use in treatment.

Philip N. Newsome, PhD, FRCPE Released: February 12, 2020

Learn about the agents in late-phase clinical trials and their potential use in treatment.

Juan Pablo Frias, MD, FACE Philip N. Newsome, PhD, FRCPE Released: January 28, 2020

Hear Brent A. Neuschwander-Tetri, MD, explore NASH screening and the interplay among NAFLD, metabolic syndrome, CV risk, and diabetes risk.

Brent A. Neuschwander-Tetri, MD Released: July 7, 2020

Hear Philip N. Newsome, PhD, FRCPE, discuss available approaches to managing NASH, including lifestyle, vitamin E, and compounds that target insulin resistance.

Philip N. Newsome, PhD, FRCPE Released: July 2, 2020

Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis.

Philip N. Newsome, PhD, FRCPE Released: July 1, 2020

Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests for NASH.

Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: July 7, 2020

What should our patients with NAFLD eat? Listen as expert hepatologist Rotonya Carr, MD, explores the evidence behind different diets in NAFLD/NASH.

Rotonya Carr, MD Released: July 8, 2020